|
1
|
Saini V, Guada L and Yavagal DR: Global
epidemiology of stroke and access to acute ischemic stroke
interventions. Neurology. 97 (20 Suppl 2):S6–S16. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benjamin EJ, Virani SS, Callaway CW,
Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling
FN, Deo R, et al: Heart disease and stroke statistics-2018 update:
A report from the American heart association. Circulation.
137:e67–e492. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang JL, Mukda S and Chen SD: Diverse
roles of mitochondria in ischemic stroke. Redox Biol. 16:263–275.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu D, Chen J, Wu L, Lee H, Shi J, Zhang M,
Ma Y, He X, Zhu Z, Yan F, et al: A clinically relevant model of
focal embolic cerebral ischemia by thrombus and thrombolysis in
rhesus monkeys. Nat Protoc. 17:2054–2084. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Chen L, Yao ZM, Sun XR, Tong XH
and Dong SY: The role of mitochondrial dynamics in cerebral
ischemia-reperfusion injury. Biomed Pharmacother. 162:1146712023.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
An H, Zhou B and Ji X: Mitochondrial
quality control in acute ischemic stroke. J Cereb Blood Flow Metab.
41:3157–3170. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Monsour M and Borlongan CV: The central
role of peripheral inflammation in ischemic stroke. J Cereb Blood
Flow Metab. 43:622–641. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ludhiadch A, Sharma R, Muriki A and Munshi
A: Role of calcium homeostasis in ischemic stroke: A review. CNS
Neurol Disord Drug Targets. 21:52–61. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng D, Liu J, Piao H, Zhu Z, Wei R and
Liu K: ROS-triggered endothelial cell death mechanisms: Focus on
pyroptosis, parthanatos, and ferroptosis. Front Immunol.
13:10392412022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chamorro Á, Dirnagl U, Urra X and Planas
AM: Neuroprotection in acute stroke: Targeting excitotoxicity,
oxidative and nitrosative stress, and inflammation. Lancet Neurol.
15:869–881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lugovaya AV, Emanuel TS, Kalinina NM,
Mitreikin VP, Artemova AV and Makienko AA: The role of autophagy in
the regulation of neuroinflammation in acute ischemic stroke
(review of literature). Klin Lab Diagn. 67:391–398. 2022.PubMed/NCBI
|
|
12
|
Jurcau A and Simion A: Neuroinflammation
in cerebral ischemia and ischemia/reperfusion injuries: From
pathophysiology to therapeutic strategies. Int J Mol Sci.
23:142021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martinon F, Burns K and Tschopp J: The
inflammasome: A molecular platform triggering activation of
inflammatory caspases and processing of proIL-beta. Mol Cell.
10:417–426. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia S, Yang H, Huang F and Fan W: Systemic
inflammation, neuroinflammation and perioperative neurocognitive
disorders. Inflamm Res. 72:1895–1907. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vringer E and Tait SWG: Mitochondria and
cell death-associated inflammation. Cell Death Differ. 30:304–312.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao S, Li X, Wang J and Wang H: The role
of the effects of autophagy on NLRP3 inflammasome in inflammatory
nervous system diseases. Front Cell Dev Biol. 9:6574782021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu J and Wu H: Structural mechanisms of
NLRP3 inflammasome assembly and activation. Annu Rev Immunol.
41:301–316. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mangan MSJ, Olhava EJ, Roush WR, Seidel
HM, Glick GD and Latz E: Targeting the NLRP3 inflammasome in
inflammatory diseases. Nat Rev Drug Discov. 17:588–606. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Xu W and Zhou R: NLRP3
inflammasome activation and cell death. Cell Mol Immunol.
18:2114–2127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vajjhala PR, Mirams RE and Hill JM:
Multiple binding sites on the pyrin domain of ASC protein allow
self-association and interaction with NLRP3 protein. J Biol Chem.
287:41732–31743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kelley N, Jeltema D, Duan Y and He Y: The
NLRP3 inflammasome: An overview of mechanisms of activation and
regulation. Int J Mol Sci. 20:33282019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abais JM, Xia M, Zhang Y, Boini KM and Li
PL: Redox regulation of NLRP3 inflammasomes: ROS as trigger or
effector? Antioxid Redox Signal. 22:1111–1129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toldo S and Abbate A: The NLRP3
inflammasome in acute myocardial infarction. Nat Rev Cardiol.
15:203–214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swanson KV, Deng M and Ting JP: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Wang H, Kouadir M, Song H and Shi
F: Recent advances in the mechanisms of NLRP3 inflammasome
activation and its inhibitors. Cell Death Dis. 10:1282019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nunes PR, Mattioli SV and Sandrim VC:
NLRP3 activation and its relationship to endothelial dysfunction
and oxidative stress: Implications for preeclampsia and
pharmacological interventions. Cells. 10:28282021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu J and Núñez G: The NLRP3 inflammasome:
Activation and regulation. Trends Biochem Sci. 48:331–344. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Frank D and Vince JE: Pyroptosis versus
necroptosis: Similarities, differences, and crosstalk. Cell Death
Differ. 26:99–114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi J, Gao W and Shao F: Pyroptosis:
Gasdermin-mediated programmed necrotic cell death. Trends Biochem
Sci. 42:245–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang C and Ruan J: Mechanistic insights
into gasdermin pore formation and regulation in pyroptosis. J Mol
Biol. 434:1672972022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zou J, Zheng Y, Huang Y, Tang D, Kang R
and Chen R: The versatile gasdermin family: Their function and
roles in diseases. Front Immunol. 12:7515332021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Long J, Sun Y, Liu S, Yang S, Chen C,
Zhang Z, Chu S, Yang Y, Pei G, Lin M, et al: Targeting pyroptosis
as a preventive and therapeutic approach for stroke. Cell Death
Discov. 9:1552023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Franke M, Bieber M, Kraft P, Weber ANR,
Stoll G and Schuhmann MK: The NLRP3 inflammasome drives
inflammation in ischemia/reperfusion injury after transient middle
cerebral artery occlusion in mice. Brain Behav Immun. 92:223–233.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Abulafia DP, de Rivero Vaccari JP, Lozano
JD, Lotocki G, Keane RW and Dietrich WD: Inhibition of the
inflammasome complex reduces the inflammatory response after
thromboembolic stroke in mice. J Cereb Blood Flow Metab.
29:534–544. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Ren W, Wu Q, Liu T, Wei Y, Ding J,
Zhou C, Xu H and Yang S: NLRP3 inflammasome activation: A
therapeutic target for cerebral ischemia-reperfusion injury. Front
Mol Neurosci. 15:8474402022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ismael S, Zhao L, Nasoohi S and Ishrat T:
Inhibition of the NLRP3-inflammasome as a potential approach for
neuroprotection after stroke. Sci Rep. 8:59712018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hong P, Li FX, Gu RN, Fang YY, Lai LY,
Wang YW, Tao T, Xu SY, You ZJ and Zhang HF: Inhibition of NLRP3
inflammasome ameliorates cerebral ischemia-reperfusion injury in
diabetic mice. Neural Plast. 2018:91635212018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ward R, Li W, Abdul Y, Jackson L, Dong G,
Jamil S, Filosa J, Fagan SC and Ergul A: NLRP3 inflammasome
inhibition with MCC950 improves diabetes-mediated cognitive
impairment and vasoneuronal remodeling after ischemia. Pharmacol
Res. 142:237–250. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu H, Meng Y, Han X and Zhang W: ADAM8
activates NLRP3 inflammasome to promote cerebral
ischemia-reperfusion injury. J Healthc Eng. 2021:30974322021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bellut M, Papp L, Bieber M, Kraft P, Stoll
G and Schuhmann MK: NLPR3 inflammasome inhibition alleviates
hypoxic endothelial cell death in vitro and protects blood-brain
barrier integrity in murine stroke. Cell Death Dis. 13:202021.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ahmad M, Dar NJ, Bhat ZS, Hussain A, Shah
A, Liu H and Graham SH: Inflammation in ischemic stroke:
Mechanisms, consequences and possible drug targets. CNS Neurol
Disord Drug Targets. 13:1378–1396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li P, Li S, Wang L, Li H, Wang Y, Liu H,
Wang X, Zhu X, Liu Z, Ye F and Zhang Y: Mitochondrial dysfunction
in hearing loss: Oxidative stress, autophagy and NLRP3
inflammasome. Front Cell Dev Biol. 11:11197732023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Minutoli L, Puzzolo D, Rinaldi M, Irrera
N, Marini H, Arcoraci V, Bitto A, Crea G, Pisani A, Squadrito F, et
al: ROS-mediated NLRP3 inflammasome activation in brain, heart,
kidney, and testis ischemia/reperfusion injury. Oxid Med Cell
Longev. 2016:21830262016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Abderrazak A, Syrovets T, Couchie D, El
Hadri K, Friguet B, Simmet T and Rouis M: NLRP3 inflammasome: From
a danger signal sensor to a regulatory node of oxidative stress and
inflammatory diseases. Redox Biol. 4:296–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mohamed IN, Ishrat T, Fagan SC and
El-Remessy AB: Role of inflammasome activation in the
pathophysiology of vascular diseases of the neurovascular unit.
Antioxid Redox Signal. 22:1188–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mohamed IN, Li L, Ismael S, Ishrat T and
El-Remessy AB: Thioredoxin interacting protein, a key molecular
switch between oxidative stress and sterile inflammation in
cellular response. World J Diabetes. 12:1979–1999. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Li J, Li S, Li Y, Wang X, Liu B, Fu
Q and Ma S: Curcumin attenuates glutamate neurotoxicity in the
hippocampus by suppression of ER stress-associated TXNIP/NLRP3
inflammasome activation in a manner dependent on AMPK. Toxicol Appl
Pharmacol. 286:53–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ishrat T, Mohamed IN, Pillai B, Soliman S,
Fouda AY, Ergul A, El-Remessy AB and Fagan SC:
Thioredoxin-interacting protein: A novel target for neuroprotection
in experimental thromboembolic stroke in mice. Mol Neurobiol.
51:766–778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Brand MD and Esteves TC: Physiological
functions of the mitochondrial uncoupling proteins UCP2 and UCP3.
Cell Metab. 2:85–93. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hass DT and Barnstable CJ: Uncoupling
proteins in the mitochondrial defense against oxidative stress.
Prog Retin Eye Res. 83:1009412021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang T, He MT, Zhang XP, Jing L and Zhang
JZ: Uncoupling protein 2 deficiency enhances NLRP3 inflammasome
activation following hyperglycemia-induced exacerbation of cerebral
ischemia and reperfusion damage in vitro and in vivo. Neurochem
Res. 46:1359–1371. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang D, Zhou J, Li W, Zhang L, Wang X and
Liu Q: Casticin protected against neuronal injury and inhibited the
TLR4/NF-κB pathway after middle cerebral artery occlusion in rats.
Pharmacol Res Perspect. 9:e007522021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bauernfeind FG, Horvath G, Stutz A,
Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks
BG, Fitzgerald KA, et al: Cutting edge: NF-kappaB activating
pattern recognition and cytokine receptors license NLRP3
inflammasome activation by regulating NLRP3 expression. J Immunol.
183:787–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhong X, Liu M, Yao W, Du K, He M, Jin X,
Jiao L, Ma G, Wei B and Wei M: Epigallocatechin-3-gallate
attenuates microglial inflammation and neurotoxicity by suppressing
the activation of canonical and noncanonical inflammasome via
TLR4/NF-κB pathway. Mol Nutr Food Res. 63:e18012302019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yao L, Cai H, Fang Q, Liu D, Zhan M, Chen
L and Du J: Piceatannol alleviates liver ischaemia/reperfusion
injury by inhibiting TLR4/NF-κB/NLRP3 in hepatic macrophages. Eur J
Pharmacol. 960:1761492023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zheng Y, Bu J, Yu L, Chen J and Liu H:
Nobiletin improves propofol-induced neuroprotection via regulating
Akt/mTOR and TLR 4/NF-κB signaling in ischemic brain injury in
rats. Biomed Pharmacother. 91:494–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shukla V, Shakya AK, Perez-Pinzon MA and
Dave KR: Cerebral ischemic damage in diabetes: An inflammatory
perspective. J Neuroinflammation. 14:212017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu M, Liu F and Guo Q: Quercetin
attenuates hypoxia-ischemia induced brain injury in neonatal rats
by inhibiting TLR4/NF-κB signaling pathway. Int Immunopharmacol.
74:1057042019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Klionsky DJ, Petroni G, Amaravadi RK,
Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K,
Cecconi F, Choi AMK, et al: Autophagy in major human diseases. EMBO
J. 40:e1088632021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lv S, Wang H and Li X: The role of the
interplay between autophagy and NLRP3 inflammasome in metabolic
disorders. Front Cell Dev Biol. 9:6341182021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang J, Wu D and Wang H: Hydrogen sulfide
plays an important protective role by influencing autophagy in
diseases. Physiol Res. 68:335–345. 2019.PubMed/NCBI
|
|
64
|
Zhu Y, Yin Q, Wei D, Yang Z, Du Y and Ma
Y: Autophagy in male reproduction. Syst Biol Reprod Med.
65:265–272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sahu R, Kaushik S, Clement CC, Cannizzo
ES, Scharf B, Follenzi A, Potolicchio I, Nieves E, Cuervo AM and
Santambrogio L: Microautophagy of cytosolic proteins by late
endosomes. Dev Cell. 20:131–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kaushik S and Cuervo AM:
Chaperone-mediated autophagy: A unique way to enter the lysosome
world. Trends Cell Biol. 22:407–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ueno T and Komatsu M: Autophagy in the
liver: Functions in health and disease. Nat Rev Gastroenterol
Hepatol. 14:170–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tooze SA and Yoshimori T: The origin of
the autophagosomal membrane. Nat Cell Biol. 12:831–835. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mizushima N, Yoshimori T and Ohsumi Y: The
role of Atg proteins in autophagosome formation. Annu Rev Cell Dev
Biol. 27:107–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
McCarty MF: Nutraceutical and dietary
strategies for up-regulating macroautophagy. Int J Mol Sci.
23:20542022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
He Q, Li Z, Meng C, Wu J, Zhao Y and Zhao
J: Parkin-dependent mitophagy is required for the inhibition of
ATF4 on NLRP3 inflammasome activation in cerebral
ischemia-reperfusion injury in rats. Cells. 8:8972019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cao Z, Wang Y, Long Z and He G:
Interaction between autophagy and the NLRP3 inflammasome. Acta
Biochim Biophys Sin (Shanghai). 51:1087–1095. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Biasizzo M and Kopitar-Jerala N: Interplay
between NLRP3 inflammasome and autophagy. Front Immunol.
11:5918032020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang H, Yu M, Ochani M, Amella CA, Tanovic
M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al: Nicotinic
acetylcholine receptor alpha7 subunit is an essential regulator of
inflammation. Nature. 421:384–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Jiang T, Wu M, Zhang Z, Yan C, Ma Z, He S,
Yuan W, Pu K and Wang Q: Electroacupuncture attenuated cerebral
ischemic injury and neuroinflammation through α7nAChR-mediated
inhibition of NLRP3 inflammasome in stroke rats. Mol Med.
25:222019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu L, Chen M, Lin K, Xiang X, Zheng Y and
Zhu S: Inhibiting caspase-12 mediated inflammasome activation
protects against oxygen-glucose deprivation injury in primary
astrocytes. Int J Med Sci. 17:1936–1945. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lin X, Zhan J, Jiang J and Ren Y:
Upregulation of neuronal cylindromatosis expression is essential
for electroacupuncture-mediated alleviation of neuroinflammatory
injury by regulating microglial polarization in rats subjected to
focal cerebral ischemia/reperfusion. J Inflamm Res. 14:2061–2078.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ito M, Shichita T, Okada M, Komine R,
Noguchi Y, Yoshimura A and Morita R: Bruton's tyrosine kinase is
essential for NLRP3 inflammasome activation and contributes to
ischaemic brain injury. Nat Commun. 6:73602015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Franchi L, Warner N, Viani K and Nuñez G:
Function of nod-like receptors in microbial recognition and host
defense. Immunol Rev. 227:106–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li Y and Jiang Q: Uncoupled pyroptosis and
IL-1β secretion downstream of inflammasome signaling. Front
Immunol. 14:11283582023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Dinarello CA: Immunological and
inflammatory functions of the interleukin-1 family. Annu Rev
Immunol. 27:519–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sun R, Peng M, Xu P, Huang F, Xie Y, Li J,
Hong Y, Guo H, Liu Q and Zhu W: Low-density lipoprotein receptor
(LDLR) regulates NLRP3-mediated neuronal pyroptosis following
cerebral ischemia/reperfusion injury. J Neuroinflammation.
17:3302020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lyu Z, Chan Y, Li Q, Zhang Q, Liu K, Xiang
J, Li X, Cai D, Li Y, Wang B and Yu Z: Destructive effects of
pyroptosis on homeostasis of neuron survival associated with the
dysfunctional BBB-glymphatic system and amyloid-beta accumulation
after cerebral ischemia/reperfusion in rats. Neural Plast.
2021:45043632021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liu J, Zheng J, Xu Y, Cao W, Wang J, Wang
B, Zhao L, Zhang X and Liao W: Enriched environment attenuates
pyroptosis to improve functional recovery after cerebral
ischemia/reperfusion injury. Front Aging Neurosci. 13:7176442021.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Pang YQ, Yang J, Jia CM, Zhang R and Pang
Q: Hypoxic preconditioning reduces NLRP3 inflammasome expression
and protects against cerebral ischemia/reperfusion injury. Neural
Regen Res. 17:395–400. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen
L and Xie Y: Protective effects of remimazolam on cerebral
ischemia/reperfusion injury in rats by inhibiting of NLRP3
inflammasome-dependent pyroptosis. Drug Des Devel Ther. 16:413–423.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhu T, Fang BY, Meng XB, Zhang SX, Wang H,
Gao G, Liu F, Wu Y, Hu J, Sun GB and Sun XB: Folium Ginkgo extract
and tetramethylpyrazine sodium chloride injection (Xingxiong
injection) protects against focal cerebral ischaemia/reperfusion
injury via activating the Akt/Nrf2 pathway and inhibiting NLRP3
inflammasome activation. Pharm Biol. 60:195–205. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Mo ZT, Zheng J and Liao YL: Icariin
inhibits the expression of IL-1β, IL-6 and TNF-α induced by OGD/R
through the IRE1/XBP1s pathway in microglia. Pharm Biol.
59:1473–1479. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Shang S, Sun F, Zhu Y, Yu J, Yu L, Shao W,
Wang Z and Yi X: Sevoflurane preconditioning improves
neuroinflammation in cerebral ischemia/reperfusion induced rats
through ROS-NLRP3 pathway. Neurosci Lett. 801:1371642023.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin
M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates
cerebral ischemia-induced blood-brain barrier dysfunction by
suppressing TXNIP/NLRP3 inflammasome activation and the MAPK
pathway. Int J Mol Sci. 17:14182016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Li Y, Wang R, Xue L, Yang Y and Zhi F:
Astilbin protects against cerebral ischaemia/reperfusion injury by
inhibiting cellular apoptosis and ROS-NLRP3 inflammasome axis
activation. Int Immunopharmacol. 84:1065712020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhao J, Piao X, Wu Y, Liang S, Han F,
Liang Q, Shao S and Zhao D: Cepharanthine attenuates cerebral
ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced
inflammation and oxidative stress via inhibiting 12/15-LOX
signaling. Biomed Pharmacother. 127:1101512020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Amruta N and Bix G: ATN-161 ameliorates
ischemia/reperfusion-induced oxidative stress, fibro-inflammation,
mitochondrial damage, and apoptosis-mediated tight junction
disruption in bEnd.3 cells. Inflammation. 44:2377–2394. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
He J, Wu H, Zhou Y and Zheng C: Tomentosin
inhibit cerebral ischemia/reperfusion induced inflammatory response
via TLR4/NLRP3 signalling pathway-in vivo and in vitro studies.
Biomed Pharmacother. 131:1106972020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sapkota A and Choi JW: Oleanolic acid
provides neuroprotection against ischemic stroke through the
inhibition of microglial activation and NLRP3 inflammasome
activation. Biomol Ther (Seoul). 30:55–63. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Cui HX, Chen JH, Li JW, Cheng FR and Yuan
K: Protection of anthocyanin from Myrica rubra against
cerebral ischemia-reperfusion injury via modulation of the
TLR4/NF-κB and NLRP3 pathways. Molecules. 23:17882018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ye Y, Jin T, Zhang X, Zeng Z, Ye B, Wang
J, Zhong Y, Xiong X and Gu L: Meisoindigo protects against focal
cerebral ischemia-reperfusion injury by inhibiting NLRP3
inflammasome activation and regulating microglia/macrophage
polarization via TLR4/NF-κB signaling pathway. Front Cell Neurosci.
13:5532019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Dai M, Wu L, Yu K, Xu R, Wei Y,
Chinnathambi A, Alahmadi TA and Zhou M: D-Carvone inhibit cerebral
ischemia/reperfusion induced inflammatory response TLR4/NLRP3
signaling pathway. Biomed Pharmacother. 132:1108702020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang K, Ru J, Zhang H, Chen J, Lin X, Lin
Z, Wen M, Huang L, Ni H, Zhuge Q and Yang S: Melatonin enhances the
therapeutic effect of plasma exosomes against cerebral
ischemia-induced pyroptosis through the TLR4/NF-κB pathway. Front
Neurosci. 14:8482020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Han D, Wang J, Wen L, Sun M, Liu H and Gao
Y: Vinpocetine attenuates ischemic stroke through inhibiting NLRP3
inflammasome expression in mice. J Cardiovasc Pharmacol.
77:208–216. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Liu J, Ma W, Zang CH, Wang GD, Zhang SJ,
Wu HJ, Zhu KW, Xiang XL, Li CY, Liu KP, et al: Salidroside inhibits
NLRP3 inflammasome activation and apoptosis in microglia induced by
cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB
signaling pathway. Ann Transl Med. 9:16942021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Ran Y, Su W, Gao F, Ding Z, Yang S, Ye L,
Chen X, Tian G, Xi J and Liu Z: Curcumin ameliorates white matter
injury after ischemic stroke by inhibiting microglia/macrophage
pyroptosis through NF-κB suppression and NLRP3 inflammasome
inhibition. Oxid Med Cell Longev. 2021:15521272021. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhao Y, Hong Z, Lin Y, Shen W, Yang Y, Zuo
Z and Hu X: Exercise pretreatment alleviates neuroinflammation and
oxidative stress by TFEB-mediated autophagic flux in mice with
ischemic stroke. Exp Neurol. 364:1143802023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zeng Q, Zhou Y, Liang D, He H, Liu X, Zhu
R, Zhang M, Luo X, Wang Y and Huang G: Exosomes secreted from bone
marrow mesenchymal stem cells attenuate oxygen-glucose
deprivation/reoxygenation-induced pyroptosis in PC12 cells by
promoting AMPK-dependent autophagic flux. Front Cell Neurosci.
14:1822020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Hu Z, Yuan Y, Zhang X, Lu Y, Dong N, Jiang
X, Xu J and Zheng D: Human umbilical cord mesenchymal stem
cell-derived exosomes attenuate oxygen-glucose
deprivation/reperfusion-induced microglial pyroptosis by promoting
FOXO3a-dependent mitophagy. Oxid Med Cell Longev. 2021:62197152021.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Huang Z, Zhou X, Zhang X, Huang L, Sun Y,
Cheng Z, Xu W, Li CG, Zheng Y and Huang M: Pien-Tze-Huang, a
Chinese patent formula, attenuates NLRP3 inflammasome-related
neuroinflammation by enhancing autophagy via the AMPK/mTOR/ULK1
signaling pathway. Biomed Pharmacother. 141:1118142021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ma C, Wang X, Xu T, Yu X, Zhang S, Liu S,
Gao Y, Fan S, Li C, Zhai C, et al: Qingkailing injection
ameliorates cerebral ischemia-reperfusion injury and modulates the
AMPK/NLRP3 inflammasome signalling pathway. BMC Complement Altern
Med. 19:3202019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Xiao L, Dai Z, Tang W, Liu C and Tang B:
Astragaloside IV alleviates cerebral ischemia-reperfusion injury
through NLRP3 inflammasome-mediated pyroptosis inhibition via
activating Nrf2. Oxid Med Cell Longev. 2021:99255612021. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Tang H, Li J, Zhou Q, Li S, Xie C, Niu L,
Ma J and Li C: Vagus nerve stimulation alleviated cerebral ischemia
and reperfusion injury in rats by inhibiting pyroptosis via α7
nicotinic acetylcholine receptor. Cell Death Discov. 8:542022.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhang Y, Wang H, Li H, Nan L, Xu W, Lin Y
and Chu K: Gualou guizhi granule protects against OGD/R-induced
injury by inhibiting cell pyroptosis via the PI3K/Akt signaling
pathway. Evid Based Complement Alternat Med.
2021:66135722021.PubMed/NCBI
|
|
114
|
Wang B, Lyu Z, Chan Y, Li Q, Zhang L, Liu
K, Li Y and Yu Z: Tongxinluo exerts inhibitory effects on
pyroptosis and amyloid-β peptide accumulation after cerebral
ischemia/reperfusion in rats. Evid Based Complement Alternat Med.
2021:57886022021.PubMed/NCBI
|
